Jun Koshio
Date, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Real-world comparative effectiveness of atezolizumab versus durvalumab for extensive-stage small-cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: December 15, 2025
Phase II Trial of the Combination of Alectinib with Bevacizumab in Alectinib Refractory ALK-Positive Nonsquamous Non-Small-Cell Lung Cancer (NLCTG1501).
Journal: Cancers
Published: December 05, 2022
Efficacy and safety of amrubicin therapy after chemoimmunotherapy in small cell lung cancer patients.
Journal: Translational lung cancer research
Published: March 23, 2022
Observational study of rebiopsy in EGFR-TKI-resistant patients with EGFR mutation-positive advanced NSCLC.
Journal: Scientific reports
Published: November 17, 2021
Panniculitis as the initial manifestation of dermatomyositis with anti-MDA5 antibody.
Journal: Clinical and experimental dermatology
Published: October 10, 2016
Critical Roles of Chemoresistant Effector and Regulatory T Cells in Antitumor Immunity after Lymphodepleting Chemotherapy.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: June 10, 2014
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 3, X-linked is an immunogenic target of cancer stem cells.
Journal: Cancer immunology, immunotherapy : CII
Published: May 21, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026